| # | Drug | Count |
|---|---|---|
| 0 | RUXOLITINIB | 944 |
| 1 | HYDROXYUREA | 275 |
| 2 | ASPIRIN | 176 |
| 3 | ASPIRIN 325 MG | 168 |
| 4 | ASPIRIN 81 MG | 168 |
| 5 | ROMIPLOSTIM | 157 |
| 6 | ALLOPURINOL | 152 |
| 7 | FUROSEMIDE | 126 |
| 8 | DEFERASIROX | 120 |
| 9 | ELTROMBOPAG OLAMINE | 109 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TIMOLOL HEMIHYDRATE | 1 | 0.0769 |
| 1 | MOMELOTINIB | 96 | 0.0648 |
| 2 | ANAGRELIDE HYDROCHLORIDE | 41 | 0.0349 |
| 3 | ALUMINUM CHLOROHYDRATE | 1 | 0.0222 |
| 4 | HYDROXYUREA | 275 | 0.0129 |
| 5 | RUXOLITINIB | 944 | 0.0129 |
| 6 | DANAZOL | 36 | 0.0127 |
| 7 | FEDRATINIB HYDROCHLORIDE | 17 | 0.0126 |
| 8 | PACRITINIB | 35 | 0.0114 |
| 9 | ROMIPLOSTIM | 157 | 0.0103 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 1007 |
| 1 | Janus Kinase Inhibitor [EPC] | 947 |
| 2 | Antimetabolite [EPC] | 275 |
| 3 | Corticosteroid [EPC] | 247 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 240 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 182 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 164 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 157 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 141 |
| 9 | Loop Diuretic [EPC] | 138 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 157 | 0.0103 |
| 1 | Complement Factor D Inhibitor [EPC] | 3 | 0.0097 |
| 2 | Interferon alfa-2b [EPC] | 17 | 0.0091 |
| 3 | Janus Kinase Inhibitor [EPC] | 947 | 0.0059 |
| 4 | Erythroid Maturation Agent [EPC] | 11 | 0.0042 |
| 5 | Iron Chelator [EPC] | 123 | 0.0042 |
| 6 | Kinase Inhibitor [EPC] | 1007 | 0.0018 |
| 7 | Androgen [EPC] | 41 | 0.0015 |
| 8 | Xanthine Oxidase Inhibitor [EPC] | 164 | 0.0009 |
| 9 | CD33-directed Immunoconjugate [EPC] | 3 | 0.0008 |